File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/01.rli.0000167125.79212.5d
- Scopus: eid_2-s2.0-20844433248
- PMID: 15973131
- WOS: WOS:000230018100003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration
Title | Evaluation of <sup>1</sup>H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration |
---|---|
Authors | |
Keywords | Breast cancer Breast MRI Choline Contrast MR spectroscopy |
Issue Date | 2005 |
Citation | Investigative Radiology, 2005, v. 40, n. 7, p. 405-411 How to Cite? |
Abstract | Objectives: We sought to evaluate spectroscopic measurements in breast cancer and compare variability in choline peak parameters related to contrast administration versus that inherent to repeated measurements. Materials and Methods: Single-voxel, proton spectroscopy measurements were obtained before and after the administration of gadolinium on 15 patients with ≥1-cm breast cancers. The protocol was repeated on a separate day in 7 patients. Results: Postcontrast spectra demonstrated a significant increase in choline peak linewidth (day 1: 15% ± 21%, P = 0.03; day 2: 19% ± 12%, P = 0.001) and decrease in choline peak area (day 1: 11% ± 9% (P < 0.001); day 2: 18% ± 21% (P = 0.03). A variance-components analysis indicated that day-to-day variation in linewidth accounted for 0.0% of the total variation in width measurements and was not significant (P = 0.85). Day-to-day variation in area was also not significant (0.0%, P = 0.95). Conclusions: Contrast administration caused significant increases in choline peak linewidth and decreases in choline peak area in spectroscopic measurements of breast cancer. Copyright © 2005 by Lippincott Williams & Wilkins. |
Persistent Identifier | http://hdl.handle.net/10722/315958 |
ISSN | 2023 Impact Factor: 7.0 2023 SCImago Journal Rankings: 2.458 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Joe, Bonnie N. | - |
dc.contributor.author | Chen, Victoria Y. | - |
dc.contributor.author | Salibi, Nouha | - |
dc.contributor.author | Fuangtharntip, Pornpim | - |
dc.contributor.author | Hildebolt, Charles F. | - |
dc.contributor.author | Bae, Kyongtae T. | - |
dc.date.accessioned | 2022-08-24T15:48:44Z | - |
dc.date.available | 2022-08-24T15:48:44Z | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Investigative Radiology, 2005, v. 40, n. 7, p. 405-411 | - |
dc.identifier.issn | 0020-9996 | - |
dc.identifier.uri | http://hdl.handle.net/10722/315958 | - |
dc.description.abstract | Objectives: We sought to evaluate spectroscopic measurements in breast cancer and compare variability in choline peak parameters related to contrast administration versus that inherent to repeated measurements. Materials and Methods: Single-voxel, proton spectroscopy measurements were obtained before and after the administration of gadolinium on 15 patients with ≥1-cm breast cancers. The protocol was repeated on a separate day in 7 patients. Results: Postcontrast spectra demonstrated a significant increase in choline peak linewidth (day 1: 15% ± 21%, P = 0.03; day 2: 19% ± 12%, P = 0.001) and decrease in choline peak area (day 1: 11% ± 9% (P < 0.001); day 2: 18% ± 21% (P = 0.03). A variance-components analysis indicated that day-to-day variation in linewidth accounted for 0.0% of the total variation in width measurements and was not significant (P = 0.85). Day-to-day variation in area was also not significant (0.0%, P = 0.95). Conclusions: Contrast administration caused significant increases in choline peak linewidth and decreases in choline peak area in spectroscopic measurements of breast cancer. Copyright © 2005 by Lippincott Williams & Wilkins. | - |
dc.language | eng | - |
dc.relation.ispartof | Investigative Radiology | - |
dc.subject | Breast cancer | - |
dc.subject | Breast MRI | - |
dc.subject | Choline | - |
dc.subject | Contrast | - |
dc.subject | MR spectroscopy | - |
dc.title | Evaluation of <sup>1</sup>H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1097/01.rli.0000167125.79212.5d | - |
dc.identifier.pmid | 15973131 | - |
dc.identifier.scopus | eid_2-s2.0-20844433248 | - |
dc.identifier.volume | 40 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 405 | - |
dc.identifier.epage | 411 | - |
dc.identifier.isi | WOS:000230018100003 | - |